Global Ocular Hypertension Clinical Trials And Research Reports 2014: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report

MarketResearchReports.Biz announces addition of new report “Global Ocular Hypertension Clinical Trials And Research Reports 2014” to its database. Visit: http://www.marketresearchreports.biz/analysis/186897.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketResearchReports.biz

MarketResearchReports.biz

Albany, NY (PRWEB) February 08, 2014

Ocular Hypertension Global Clinical Trials Review, H1, 2014

"Ocular Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis/186897.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  •     Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  •     Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  •     Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  •     Understand the dynamics of a particular indication in a condensed manner
  •     Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  •     Obtain discontinued trial listing for trials across the globe
  •     Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content

List of Tables
List of Figures

Introduction
Ocular Hypertension
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Ocular Hypertension
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Ocular Hypertension
Sep 27, 2012: Amakem Initiates Phase IIa Proof Of Concept Study With AMA0076 In Patients With Glaucoma And Ocular Hypertension
Aug 20, 2012: Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study For Treatment Of Glaucoma
Jun 13, 2012: Zeltia Subsidiary Sylentis Commences Phase II Clinical Trial With SYL040012 For Treatment Of Ocular Hypertension Associated With Glaucoma
Mar 13, 2012: NicOx, Bausch + Lomb\'s Glaucoma Candidate BOL-303259-X Meets Primary Endpoint In Phase IIb Study
Feb 09, 2012: Altheos Initiates Phase IIa Clinical Trial For Its Lead Glaucoma Drug Candidate, ATS907

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186897.

Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Allergan, Inc.
Clinical Trial Overview of Allergan, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Santen Pharmaceutical Co., Ltd. 52
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Kowa Company, Ltd.
Clinical Trial Overview of Kowa Company, Ltd.
QLT Inc.
Clinical Trial Overview of QLT Inc.
Aerie Pharmaceuticals, Inc.
Clinical Trial Overview of Aerie Pharmaceuticals, Inc.
Mati Therapeutics Inc.
Clinical Trial Overview of Mati Therapeutics Inc.
Bausch & Lomb Incorporated
Clinical Trial Overview of Bausch & Lomb Incorporated
Clinical Trial Overview of Top Institutes / Government
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Aristotle University Of Thessaloniki
Clinical Trial Overview of Aristotle University Of Thessaloniki

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis-details/ocular-hypertension-global-clinical-trials-review-h1-2014

University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
The University of Tokyo
Clinical Trial Overview of The University of Tokyo
Meir Medical Center
Clinical Trial Overview of Meir Medical Center
Department of Health, South Africa 65
Clinical Trial Overview of Department of Health, South Africa
National Eye Institute
Clinical Trial Overview of National Eye Institute
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Walter Reed Army Medical Center
Clinical Trial Overview of Walter Reed Army Medical Center
Universita di Bologna
Clinical Trial Overview of Universita di Bologna
Five Key Clinical Profiles

Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Contact US:

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales(at)marketresearchreports(dot)biz
Web: http://www.marketresearchreports.biz/
Blog: http://articlesnarticles.blogspot.com/